

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.61084506 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.46239899 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.46239899 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.46239899 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.46239899 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.46239899 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.46239899 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.45816341 |
| 9 | positive regulation of B cell differentiation (GO:0045579) | 4.44278927 |
| 10 | mannose metabolic process (GO:0006013) | 4.20050594 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.05912864 |
| 12 | definitive hemopoiesis (GO:0060216) | 3.87801821 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84536511 |
| 14 | neutrophil activation involved in immune response (GO:0002283) | 3.76366872 |
| 15 | lymphoid progenitor cell differentiation (GO:0002320) | 3.60874405 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.60410088 |
| 17 | response to host immune response (GO:0052572) | 3.60410088 |
| 18 | negative regulation of cell killing (GO:0031342) | 3.59883539 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59883539 |
| 20 | regulation of B cell differentiation (GO:0045577) | 3.56790627 |
| 21 | dendritic cell chemotaxis (GO:0002407) | 3.52260399 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52160124 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52160124 |
| 24 | response to host (GO:0075136) | 3.49164263 |
| 25 | response to host defenses (GO:0052200) | 3.49164263 |
| 26 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.49164263 |
| 27 | daunorubicin metabolic process (GO:0044597) | 3.48243095 |
| 28 | polyketide metabolic process (GO:0030638) | 3.48243095 |
| 29 | doxorubicin metabolic process (GO:0044598) | 3.48243095 |
| 30 | leukocyte aggregation (GO:0070486) | 3.47226545 |
| 31 | dendritic cell migration (GO:0036336) | 3.37957279 |
| 32 | detection of bacterium (GO:0016045) | 3.37945830 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 3.37662397 |
| 34 | negative regulation of phagocytosis (GO:0050765) | 3.33755942 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.31403146 |
| 36 | detection of other organism (GO:0098543) | 3.31129318 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.29141959 |
| 38 | secretory granule organization (GO:0033363) | 3.28832670 |
| 39 | positive thymic T cell selection (GO:0045059) | 3.27487983 |
| 40 | defense response to protozoan (GO:0042832) | 3.22075112 |
| 41 | negative thymic T cell selection (GO:0045060) | 3.20930063 |
| 42 | germinal center formation (GO:0002467) | 3.20138069 |
| 43 | negative regulation of granulocyte differentiation (GO:0030853) | 3.17817975 |
| 44 | microglial cell activation (GO:0001774) | 3.15998237 |
| 45 | platelet dense granule organization (GO:0060155) | 3.15757326 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14764827 |
| 47 | regulation of antigen processing and presentation (GO:0002577) | 3.14312322 |
| 48 | cellular extravasation (GO:0045123) | 3.13977231 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.13575483 |
| 50 | pyrimidine dimer repair (GO:0006290) | 3.12886679 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.12221814 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12095451 |
| 53 | T cell migration (GO:0072678) | 3.10316694 |
| 54 | positive regulation of granulocyte differentiation (GO:0030854) | 3.09169292 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.08430178 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06699604 |
| 57 | negative T cell selection (GO:0043383) | 3.00543303 |
| 58 | B cell homeostasis (GO:0001782) | 2.96589821 |
| 59 | regulation of telomere maintenance (GO:0032204) | 2.94556044 |
| 60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94150839 |
| 61 | response to protozoan (GO:0001562) | 2.93577109 |
| 62 | mast cell activation (GO:0045576) | 2.93076598 |
| 63 | energy homeostasis (GO:0097009) | 2.92121088 |
| 64 | tRNA methylation (GO:0030488) | 2.91710357 |
| 65 | Peyers patch development (GO:0048541) | 2.89589739 |
| 66 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.89589739 |
| 67 | megakaryocyte development (GO:0035855) | 2.89157885 |
| 68 | interferon-gamma production (GO:0032609) | 2.87740003 |
| 69 | response to peptidoglycan (GO:0032494) | 2.85238973 |
| 70 | regulation of granulocyte differentiation (GO:0030852) | 2.84822983 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84004005 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 2.82827678 |
| 73 | mature B cell differentiation (GO:0002335) | 2.82126061 |
| 74 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.81647744 |
| 75 | negative regulation of interleukin-8 production (GO:0032717) | 2.79362279 |
| 76 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.78983918 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78917580 |
| 78 | T cell homeostasis (GO:0043029) | 2.76382362 |
| 79 | histone H3-K4 trimethylation (GO:0080182) | 2.75721799 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 2.74617613 |
| 81 | detection of external biotic stimulus (GO:0098581) | 2.74044941 |
| 82 | cellular response to interleukin-15 (GO:0071350) | 2.73220683 |
| 83 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.73068375 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 2.72779194 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 2.71575500 |
| 86 | thymic T cell selection (GO:0045061) | 2.70895137 |
| 87 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70637514 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 2.70053890 |
| 89 | T cell selection (GO:0045058) | 2.69564033 |
| 90 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.69554804 |
| 91 | response to interferon-beta (GO:0035456) | 2.67798566 |
| 92 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67338944 |
| 93 | regulation of erythrocyte differentiation (GO:0045646) | 2.65287003 |
| 94 | mast cell activation involved in immune response (GO:0002279) | 2.62974023 |
| 95 | mast cell degranulation (GO:0043303) | 2.62974023 |
| 96 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.62299869 |
| 97 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62187539 |
| 98 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.61736450 |
| 99 | regulation of triglyceride catabolic process (GO:0010896) | 2.61213912 |
| 100 | lymphocyte homeostasis (GO:0002260) | 2.60190432 |
| 101 | lymph node development (GO:0048535) | 2.57986698 |
| 102 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57124293 |
| 103 | B cell mediated immunity (GO:0019724) | 2.56523616 |
| 104 | negative regulation of bone resorption (GO:0045779) | 2.56190512 |
| 105 | activation of MAPKKK activity (GO:0000185) | 2.55256530 |
| 106 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.55145707 |
| 107 | regulation of interferon-alpha production (GO:0032647) | 2.52843604 |
| 108 | positive regulation of B cell activation (GO:0050871) | 2.52133591 |
| 109 | embryonic hemopoiesis (GO:0035162) | 2.52116455 |
| 110 | response to interleukin-15 (GO:0070672) | 2.51732747 |
| 111 | myeloid cell activation involved in immune response (GO:0002275) | 2.51261206 |
| 112 | neutrophil mediated immunity (GO:0002446) | 2.50794195 |
| 113 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.50690764 |
| 114 | toxin transport (GO:1901998) | 2.50586613 |
| 115 | tolerance induction (GO:0002507) | 2.50471467 |
| 116 | response to type I interferon (GO:0034340) | 2.50406292 |
| 117 | negative regulation of interleukin-6 production (GO:0032715) | 2.50242440 |
| 118 | cellular response to exogenous dsRNA (GO:0071360) | 2.49382265 |
| 119 | positive T cell selection (GO:0043368) | 2.49131858 |
| 120 | hepatocyte apoptotic process (GO:0097284) | 2.48356655 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.47901082 |
| 122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.47555826 |
| 123 | myeloid dendritic cell activation (GO:0001773) | 2.47337935 |
| 124 | regulation of germinal center formation (GO:0002634) | 2.47322285 |
| 125 | modulation by virus of host process (GO:0019054) | 2.47024492 |
| 126 | pinocytosis (GO:0006907) | 2.46874794 |
| 127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.46098949 |
| 128 | leukocyte homeostasis (GO:0001776) | 2.44986905 |
| 129 | neutrophil activation (GO:0042119) | 2.44750817 |
| 130 | negative regulation of innate immune response (GO:0045824) | 2.44269325 |
| 131 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.44238961 |
| 132 | cellular response to type I interferon (GO:0071357) | 2.44222829 |
| 133 | type I interferon signaling pathway (GO:0060337) | 2.44222829 |
| 134 | macrophage activation (GO:0042116) | 2.43665741 |
| 135 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.43263657 |
| 136 | cellular response to interferon-beta (GO:0035458) | 2.43044817 |
| 137 | response to UV-B (GO:0010224) | 2.42636223 |
| 138 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42345431 |
| 139 | negative regulation of interleukin-12 production (GO:0032695) | 2.42103850 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.41944906 |
| 141 | peptide catabolic process (GO:0043171) | 2.39839856 |
| 142 | phagocytosis, engulfment (GO:0006911) | 2.39563346 |
| 143 | angiogenesis involved in wound healing (GO:0060055) | 2.39034327 |
| 144 | B cell activation involved in immune response (GO:0002312) | 2.37484248 |
| 145 | regulation of regulatory T cell differentiation (GO:0045589) | 2.37470114 |
| 146 | peptidyl-lysine trimethylation (GO:0018023) | 2.36733702 |
| 147 | positive regulation of interferon-beta production (GO:0032728) | 2.36559525 |
| 148 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35771136 |
| 149 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.34653132 |
| 150 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.33563828 |
| 151 | leukocyte degranulation (GO:0043299) | 2.33373103 |
| 152 | negative regulation of telomere maintenance (GO:0032205) | 2.32715497 |
| 153 | actin nucleation (GO:0045010) | 2.32653245 |
| 154 | L-fucose catabolic process (GO:0042355) | 2.32160135 |
| 155 | fucose catabolic process (GO:0019317) | 2.32160135 |
| 156 | L-fucose metabolic process (GO:0042354) | 2.32160135 |
| 157 | negative regulation of viral genome replication (GO:0045071) | 2.31837618 |
| 158 | NIK/NF-kappaB signaling (GO:0038061) | 2.31428176 |
| 159 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.30966722 |
| 160 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.30966722 |
| 161 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.30091301 |
| 162 | regulation of mast cell activation (GO:0033003) | 2.29664553 |
| 163 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.28837704 |
| 164 | regulation of hypersensitivity (GO:0002883) | 2.28357257 |
| 165 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.25838434 |
| 166 | negative regulation of T cell mediated immunity (GO:0002710) | 2.25752965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.72242545 |
| 2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.58701272 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.26679443 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.04186783 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.88899104 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.79020800 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.77752124 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.65354052 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.58819966 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.54950327 |
| 11 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 3.15881057 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.97279132 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.94270051 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89205466 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.74019395 |
| 16 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.72703250 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71774276 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.47518472 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.47494865 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.41977986 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.38918759 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37305423 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34229804 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.32099065 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.29779812 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29154597 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20797793 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 2.12889596 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.07279383 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03856224 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02865368 |
| 32 | GATA1_19941826_ChIP-Seq_K562_Human | 2.02279923 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01695746 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01157286 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00209660 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97505446 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.96988138 |
| 38 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.93453979 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90883587 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.87709878 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.86842745 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.86448681 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83008344 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82589228 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.82187162 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81915138 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81523834 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.78972808 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78324365 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78250528 |
| 51 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.72420157 |
| 52 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.67310781 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66247475 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66225598 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.64164596 |
| 56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63568619 |
| 57 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.63403877 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62613239 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.62496651 |
| 60 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.62071522 |
| 61 | MYB_26560356_Chip-Seq_TH1_Human | 1.61779577 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58744387 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.56824577 |
| 64 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.53512411 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.51778094 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51470682 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50615842 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46346757 |
| 69 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.45931611 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44019945 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43393372 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43115112 |
| 73 | GATA2_19941826_ChIP-Seq_K562_Human | 1.42395663 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39849213 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39567813 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38456662 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 1.37208761 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37002831 |
| 79 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33964057 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32220370 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32198238 |
| 82 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.31195227 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30236666 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27828510 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27731853 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26115939 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25723958 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25496613 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25479774 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25479158 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24261928 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.24107025 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23771937 |
| 94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20595204 |
| 95 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17922682 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17530891 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15183156 |
| 98 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.13118092 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12292346 |
| 100 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11970045 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11835890 |
| 102 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10211577 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10056463 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09316114 |
| 105 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08625675 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08237517 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07552836 |
| 108 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07381462 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06160016 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04859350 |
| 111 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01731198 |
| 112 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00350899 |
| 113 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99978891 |
| 114 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99889743 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99185527 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98884071 |
| 117 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98484597 |
| 118 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97362619 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97245610 |
| 120 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.97178692 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96021780 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95111009 |
| 123 | P300_27268052_Chip-Seq_Bcells_Human | 0.93941438 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93675682 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93051426 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92455468 |
| 127 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91968012 |
| 128 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89231352 |
| 129 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.88230051 |
| 130 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85533127 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83904569 |
| 132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.83542400 |
| 133 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.82273931 |
| 134 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82261426 |
| 135 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.79818178 |
| 136 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79448689 |
| 137 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.77446537 |
| 138 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.76177172 |
| 139 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.74964150 |
| 140 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73866210 |
| 141 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70784550 |
| 142 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70440744 |
| 143 | EWS_26573619_Chip-Seq_HEK293_Human | 0.68171047 |
| 144 | MAF_26560356_Chip-Seq_TH2_Human | 0.67327379 |
| 145 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66177421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.15835703 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.57896143 |
| 3 | MP0005671_abnormal_response_to | 3.08686635 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 2.92558845 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.83050097 |
| 6 | MP0008058_abnormal_DNA_repair | 2.61318878 |
| 7 | MP0008007_abnormal_cellular_replicative | 2.58045613 |
| 8 | MP0000015_abnormal_ear_pigmentation | 2.57283326 |
| 9 | MP0003303_peritoneal_inflammation | 2.47558318 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.37719175 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.29819913 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.28220928 |
| 13 | MP0001800_abnormal_humoral_immune | 2.27405389 |
| 14 | MP0009785_altered_susceptibility_to | 2.26062662 |
| 15 | MP0003436_decreased_susceptibility_to | 2.18767722 |
| 16 | MP0005174_abnormal_tail_pigmentation | 2.18432364 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.15272359 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.12100431 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 2.07560383 |
| 20 | MP0006292_abnormal_olfactory_placode | 2.05837488 |
| 21 | MP0003724_increased_susceptibility_to | 2.04932611 |
| 22 | MP0004947_skin_inflammation | 2.03186773 |
| 23 | MP0002419_abnormal_innate_immunity | 2.01282028 |
| 24 | MP0000465_gastrointestinal_hemorrhage | 2.00172181 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.98354438 |
| 26 | MP0000685_abnormal_immune_system | 1.98162424 |
| 27 | MP0001819_abnormal_immune_cell | 1.97911187 |
| 28 | MP0002723_abnormal_immune_serum | 1.97829626 |
| 29 | MP0002398_abnormal_bone_marrow | 1.96014473 |
| 30 | MP0009840_abnormal_foam_cell | 1.91454628 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.91330254 |
| 32 | MP0005387_immune_system_phenotype | 1.85655806 |
| 33 | MP0001790_abnormal_immune_system | 1.85655806 |
| 34 | MP0002095_abnormal_skin_pigmentation | 1.85328289 |
| 35 | MP0005025_abnormal_response_to | 1.80037341 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.76034704 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.74624494 |
| 38 | MP0000716_abnormal_immune_system | 1.70269118 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.69214530 |
| 40 | MP0010094_abnormal_chromosome_stability | 1.67970462 |
| 41 | MP0002722_abnormal_immune_system | 1.58877044 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.57476153 |
| 43 | MP0001873_stomach_inflammation | 1.55662164 |
| 44 | MP0001188_hyperpigmentation | 1.55023454 |
| 45 | MP0003111_abnormal_nucleus_morphology | 1.50392564 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.48510505 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.48510505 |
| 48 | MP0002429_abnormal_blood_cell | 1.45570452 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.43141717 |
| 50 | MP0003279_aneurysm | 1.43001224 |
| 51 | MP0002006_tumorigenesis | 1.42180978 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.37545266 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.36909338 |
| 54 | MP0000490_abnormal_crypts_of | 1.35175200 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.34708264 |
| 56 | MP0002405_respiratory_system_inflammati | 1.34040452 |
| 57 | MP0005360_urolithiasis | 1.33951338 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.29637460 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.26077158 |
| 60 | MP0003077_abnormal_cell_cycle | 1.25497012 |
| 61 | MP0000516_abnormal_urinary_system | 1.25008509 |
| 62 | MP0005367_renal/urinary_system_phenotyp | 1.25008509 |
| 63 | MP0001958_emphysema | 1.23807823 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.17242239 |
| 65 | MP0009278_abnormal_bone_marrow | 1.16549091 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 1.15808977 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.12654123 |
| 68 | MP0006082_CNS_inflammation | 1.10883250 |
| 69 | MP0003828_pulmonary_edema | 1.10677507 |
| 70 | MP0000371_diluted_coat_color | 1.10120750 |
| 71 | MP0004147_increased_porphyrin_level | 1.09625576 |
| 72 | MP0002102_abnormal_ear_morphology | 1.09501509 |
| 73 | MP0001853_heart_inflammation | 1.06633395 |
| 74 | MP0008057_abnormal_DNA_replication | 1.06440576 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.06160901 |
| 76 | MP0002933_joint_inflammation | 1.02945536 |
| 77 | MP0000249_abnormal_blood_vessel | 1.02630628 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.02585524 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.01752851 |
| 80 | MP0008004_abnormal_stomach_pH | 1.01386545 |
| 81 | MP0002928_abnormal_bile_duct | 0.99922090 |
| 82 | MP0000858_altered_metastatic_potential | 0.98673838 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.98475049 |
| 84 | MP0005164_abnormal_response_to | 0.98106219 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 0.97364496 |
| 86 | MP0009384_cardiac_valve_regurgitation | 0.97042187 |
| 87 | MP0005390_skeleton_phenotype | 0.96762722 |
| 88 | MP0001270_distended_abdomen | 0.96679879 |
| 89 | MP0009697_abnormal_copulation | 0.93825245 |
| 90 | MP0004130_abnormal_muscle_cell | 0.92845715 |
| 91 | MP0000343_altered_response_to | 0.92819230 |
| 92 | MP0002075_abnormal_coat/hair_pigmentati | 0.92690334 |
| 93 | MP0005083_abnormal_biliary_tract | 0.92563522 |
| 94 | MP0003690_abnormal_glial_cell | 0.90829452 |
| 95 | MP0005375_adipose_tissue_phenotype | 0.90377307 |
| 96 | MP0008469_abnormal_protein_level | 0.89749193 |
| 97 | MP0004381_abnormal_hair_follicle | 0.89625575 |
| 98 | MP0009764_decreased_sensitivity_to | 0.89244365 |
| 99 | MP0003943_abnormal_hepatobiliary_system | 0.88661133 |
| 100 | MP0002009_preneoplasia | 0.87849869 |
| 101 | MP0001186_pigmentation_phenotype | 0.87117761 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.85698880 |
| 103 | MP0001851_eye_inflammation | 0.84031871 |
| 104 | MP0004883_abnormal_blood_vessel | 0.83226852 |
| 105 | MP0000049_abnormal_middle_ear | 0.82672508 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.82101921 |
| 107 | MP0003866_abnormal_defecation | 0.81777868 |
| 108 | MP0003795_abnormal_bone_structure | 0.81629382 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.80359588 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.79513172 |
| 111 | MP0005365_abnormal_bile_salt | 0.79450403 |
| 112 | MP0001663_abnormal_digestive_system | 0.78882641 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.78745321 |
| 114 | MP0005670_abnormal_white_adipose | 0.78379749 |
| 115 | MP0005535_abnormal_body_temperature | 0.77739188 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.76839812 |
| 117 | MP0002998_abnormal_bone_remodeling | 0.76559342 |
| 118 | MP0000566_synostosis | 0.76309899 |
| 119 | MP0008260_abnormal_autophagy | 0.76108120 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75679959 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.75506238 |
| 122 | MP0005310_abnormal_salivary_gland | 0.75146176 |
| 123 | MP0002938_white_spotting | 0.74754626 |
| 124 | MP0000609_abnormal_liver_physiology | 0.74297574 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.74019134 |
| 126 | MP0005257_abnormal_intraocular_pressure | 0.73958218 |
| 127 | MP0003786_premature_aging | 0.73316406 |
| 128 | MP0001849_ear_inflammation | 0.73209595 |
| 129 | MP0003075_altered_response_to | 0.72959659 |
| 130 | MP0000313_abnormal_cell_death | 0.72184840 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.71981843 |
| 132 | MP0004134_abnormal_chest_morphology | 0.71822464 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.70848975 |
| 134 | MP0002971_abnormal_brown_adipose | 0.70796602 |
| 135 | MP0005275_abnormal_skin_tensile | 0.70772433 |
| 136 | MP0002132_abnormal_respiratory_system | 0.69022095 |
| 137 | MP0006054_spinal_hemorrhage | 0.67957354 |
| 138 | MP0009763_increased_sensitivity_to | 0.67293616 |
| 139 | MP0002177_abnormal_outer_ear | 0.66714221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 3.71532586 |
| 2 | Dysostosis multiplex (HP:0000943) | 3.70134218 |
| 3 | Mucopolysacchariduria (HP:0008155) | 3.70003448 |
| 4 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.70003448 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.62936717 |
| 6 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.59562513 |
| 7 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.59562513 |
| 8 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.59562513 |
| 9 | Myositis (HP:0100614) | 3.59404359 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.51482075 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.22513515 |
| 12 | Chromsome breakage (HP:0040012) | 3.10118757 |
| 13 | Chronic otitis media (HP:0000389) | 3.08622528 |
| 14 | Thrombocytosis (HP:0001894) | 3.07389699 |
| 15 | Colitis (HP:0002583) | 3.06233378 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.04765749 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01547458 |
| 18 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.99280048 |
| 19 | Broad face (HP:0000283) | 2.98509745 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 2.96899718 |
| 21 | Optic neuritis (HP:0100653) | 2.96899718 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 2.96799388 |
| 23 | Purpura (HP:0000979) | 2.92577077 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 2.92446589 |
| 25 | Fatigue (HP:0012378) | 2.86313744 |
| 26 | Aplastic anemia (HP:0001915) | 2.83631798 |
| 27 | Orchitis (HP:0100796) | 2.80395514 |
| 28 | IgM deficiency (HP:0002850) | 2.80085607 |
| 29 | Abnormality of the fingertips (HP:0001211) | 2.78422801 |
| 30 | Abnormality of the prostate (HP:0008775) | 2.77259384 |
| 31 | Inflammation of the large intestine (HP:0002037) | 2.76754750 |
| 32 | Increased IgE level (HP:0003212) | 2.73811090 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.71756009 |
| 34 | Increased serum ferritin (HP:0003281) | 2.71744694 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 2.70763297 |
| 36 | Tented upper lip vermilion (HP:0010804) | 2.64603871 |
| 37 | Myelodysplasia (HP:0002863) | 2.64339870 |
| 38 | Abnormality of iron homeostasis (HP:0011031) | 2.58849200 |
| 39 | Polycythemia (HP:0001901) | 2.56507969 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55614946 |
| 41 | Epistaxis (HP:0000421) | 2.53147397 |
| 42 | Abnormality of DNA repair (HP:0003254) | 2.51757204 |
| 43 | Complement deficiency (HP:0004431) | 2.46455977 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.46007767 |
| 45 | Syringomyelia (HP:0003396) | 2.44343385 |
| 46 | Spinal cord lesions (HP:0100561) | 2.44343385 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.44332553 |
| 48 | Meningitis (HP:0001287) | 2.44147467 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.43824268 |
| 50 | Recurrent viral infections (HP:0004429) | 2.41500385 |
| 51 | Cervical subluxation (HP:0003308) | 2.40229095 |
| 52 | Retinal atrophy (HP:0001105) | 2.38125750 |
| 53 | Abnormality of complement system (HP:0005339) | 2.37967392 |
| 54 | Joint stiffness (HP:0001387) | 2.37115448 |
| 55 | Obstructive lung disease (HP:0006536) | 2.35317031 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35317031 |
| 57 | Menorrhagia (HP:0000132) | 2.35028530 |
| 58 | Thickened calvaria (HP:0002684) | 2.33900238 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.31688243 |
| 60 | Broad alveolar ridges (HP:0000187) | 2.30862909 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.30289919 |
| 62 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29763577 |
| 63 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29763577 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29763577 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.29498269 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.26565096 |
| 67 | Gingivitis (HP:0000230) | 2.26207963 |
| 68 | Type I transferrin isoform profile (HP:0003642) | 2.25320790 |
| 69 | Eczematoid dermatitis (HP:0000976) | 2.25188548 |
| 70 | J-shaped sella turcica (HP:0002680) | 2.23892333 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 2.23702691 |
| 72 | Stomatitis (HP:0010280) | 2.19898738 |
| 73 | Hypertriglyceridemia (HP:0002155) | 2.18581147 |
| 74 | Recurrent skin infections (HP:0001581) | 2.17270971 |
| 75 | Hemoptysis (HP:0002105) | 2.15545903 |
| 76 | Acute myeloid leukemia (HP:0004808) | 2.15175365 |
| 77 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.14320109 |
| 78 | Amyloidosis (HP:0011034) | 2.12851365 |
| 79 | Abnormality of the nasal septum (HP:0000419) | 2.11100285 |
| 80 | Reticulocytopenia (HP:0001896) | 2.09848650 |
| 81 | Osteomyelitis (HP:0002754) | 2.09687554 |
| 82 | Loss of speech (HP:0002371) | 2.09276572 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08364995 |
| 84 | Hypertensive crisis (HP:0100735) | 2.08025146 |
| 85 | Granulocytopenia (HP:0001913) | 2.07143494 |
| 86 | Chronic diarrhea (HP:0002028) | 2.06490839 |
| 87 | Urethral obstruction (HP:0000796) | 2.06391775 |
| 88 | Chest pain (HP:0100749) | 2.05215645 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 2.04744710 |
| 90 | Abnormality of the intervertebral disk (HP:0005108) | 2.04371401 |
| 91 | Encephalitis (HP:0002383) | 2.03447912 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.03101425 |
| 93 | Hyperlipoproteinemia (HP:0010980) | 2.03082086 |
| 94 | Gingival bleeding (HP:0000225) | 2.02819575 |
| 95 | Amaurosis fugax (HP:0100576) | 2.02226737 |
| 96 | Abnormality of eosinophils (HP:0001879) | 1.99702034 |
| 97 | Impaired platelet aggregation (HP:0003540) | 1.99597874 |
| 98 | Abnormal platelet function (HP:0011869) | 1.99597874 |
| 99 | Spondylolisthesis (HP:0003302) | 1.99218017 |
| 100 | Arterial thrombosis (HP:0004420) | 1.98480288 |
| 101 | Birth length less than 3rd percentile (HP:0003561) | 1.97509432 |
| 102 | T lymphocytopenia (HP:0005403) | 1.96996546 |
| 103 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.96945595 |
| 104 | Increased mean platelet volume (HP:0011877) | 1.96919803 |
| 105 | Recurrent cutaneous fungal infections (HP:0011370) | 1.96660867 |
| 106 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.96660867 |
| 107 | Renal dysplasia (HP:0000110) | 1.96532009 |
| 108 | Mesangial abnormality (HP:0001966) | 1.95427623 |
| 109 | Abnormality of the metopic suture (HP:0005556) | 1.94975895 |
| 110 | Abnormality of T cell physiology (HP:0011840) | 1.94968002 |
| 111 | Emphysema (HP:0002097) | 1.94852609 |
| 112 | Pustule (HP:0200039) | 1.94618819 |
| 113 | Eosinophilia (HP:0001880) | 1.94239197 |
| 114 | Increased IgM level (HP:0003496) | 1.93969645 |
| 115 | Clubbing of toes (HP:0100760) | 1.93936514 |
| 116 | Vasculitis (HP:0002633) | 1.92314170 |
| 117 | Broad palm (HP:0001169) | 1.92008829 |
| 118 | Mediastinal lymphadenopathy (HP:0100721) | 1.91821288 |
| 119 | Hypergonadotropic hypogonadism (HP:0000815) | 1.91340043 |
| 120 | Aortic aneurysm (HP:0004942) | 1.90142553 |
| 121 | Abnormality of the nasal mucosa (HP:0000433) | 1.89728126 |
| 122 | Patchy hypopigmentation of hair (HP:0011365) | 1.88566922 |
| 123 | Cellulitis (HP:0100658) | 1.87640832 |
| 124 | Dislocated radial head (HP:0003083) | 1.86677933 |
| 125 | Pulmonary infiltrates (HP:0002113) | 1.84979814 |
| 126 | Gastrointestinal stroma tumor (HP:0100723) | 1.84195613 |
| 127 | White forelock (HP:0002211) | 1.83968955 |
| 128 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.83958476 |
| 129 | Pulmonary embolism (HP:0002204) | 1.83845689 |
| 130 | Deep philtrum (HP:0002002) | 1.83775231 |
| 131 | Vacuolated lymphocytes (HP:0001922) | 1.82995907 |
| 132 | Prostate neoplasm (HP:0100787) | 1.82696723 |
| 133 | Thyroid-stimulating hormone excess (HP:0002925) | 1.82519691 |
| 134 | Abnormality of the columella (HP:0009929) | 1.82487767 |
| 135 | Bone marrow hypocellularity (HP:0005528) | 1.81961269 |
| 136 | Thyroiditis (HP:0100646) | 1.81699548 |
| 137 | Morphological abnormality of the middle ear (HP:0008609) | 1.80936010 |
| 138 | Leukocytosis (HP:0001974) | 1.80147404 |
| 139 | Abnormality of the renal cortex (HP:0011035) | 1.80084082 |
| 140 | Keratitis (HP:0000491) | 1.79943836 |
| 141 | Prominent metopic ridge (HP:0005487) | 1.79077004 |
| 142 | Bruising susceptibility (HP:0000978) | 1.77442837 |
| 143 | Petechiae (HP:0000967) | 1.76453277 |
| 144 | Periodontitis (HP:0000704) | 1.75317113 |
| 145 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.74212676 |
| 146 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.72423441 |
| 147 | B lymphocytopenia (HP:0010976) | 1.72075837 |
| 148 | Abnormality of B cell number (HP:0010975) | 1.72075837 |
| 149 | IgG deficiency (HP:0004315) | 1.71826988 |
| 150 | Abnormality of the pleura (HP:0002103) | 1.71615539 |
| 151 | Abnormality of T cells (HP:0002843) | 1.71323699 |
| 152 | Agnosia (HP:0010524) | 1.69930240 |
| 153 | Albinism (HP:0001022) | 1.69635959 |
| 154 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.69109770 |
| 155 | Abnormality of the radial head (HP:0003995) | 1.68723467 |
| 156 | Cheilitis (HP:0100825) | 1.68182988 |
| 157 | Hypothermia (HP:0002045) | 1.67889438 |
| 158 | Decreased skull ossification (HP:0004331) | 1.66940237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.19602160 |
| 2 | ERN1 | 3.06345082 |
| 3 | TGFBR2 | 3.04965260 |
| 4 | TXK | 2.88256286 |
| 5 | MAP4K1 | 2.73572694 |
| 6 | KIT | 2.73047368 |
| 7 | TRIB3 | 2.37304271 |
| 8 | MAP2K3 | 2.34210355 |
| 9 | STK16 | 2.33302097 |
| 10 | TGFBR1 | 2.13639628 |
| 11 | PIK3CG | 2.10419976 |
| 12 | ADRBK2 | 2.06439926 |
| 13 | TAOK2 | 2.04538357 |
| 14 | IRAK4 | 2.04122317 |
| 15 | BTK | 1.99761594 |
| 16 | BLK | 1.97828222 |
| 17 | CDK8 | 1.93057910 |
| 18 | GRK6 | 1.92880523 |
| 19 | CSF1R | 1.87923886 |
| 20 | TEC | 1.84234747 |
| 21 | MAP3K13 | 1.80125239 |
| 22 | ICK | 1.75055554 |
| 23 | IKBKE | 1.73941920 |
| 24 | YES1 | 1.70128486 |
| 25 | MAP3K14 | 1.67209639 |
| 26 | MKNK2 | 1.63644040 |
| 27 | MKNK1 | 1.52662198 |
| 28 | MAP3K6 | 1.45631891 |
| 29 | PIM2 | 1.41397189 |
| 30 | IKBKB | 1.41162132 |
| 31 | MAPK7 | 1.39606445 |
| 32 | ZAP70 | 1.37017750 |
| 33 | TYK2 | 1.35572362 |
| 34 | BMPR1B | 1.34296154 |
| 35 | IRAK3 | 1.31658659 |
| 36 | SGK2 | 1.31094695 |
| 37 | GRK7 | 1.28859053 |
| 38 | VRK1 | 1.28095346 |
| 39 | SIK3 | 1.25438134 |
| 40 | FGFR3 | 1.24866237 |
| 41 | MAP2K2 | 1.23174890 |
| 42 | FLT3 | 1.23159075 |
| 43 | ERBB3 | 1.21799427 |
| 44 | MAP3K7 | 1.19549951 |
| 45 | EEF2K | 1.19048149 |
| 46 | SYK | 1.17955301 |
| 47 | ZAK | 1.17661141 |
| 48 | MAP3K3 | 1.15786544 |
| 49 | EIF2AK2 | 1.14186777 |
| 50 | RPS6KA4 | 1.13890690 |
| 51 | HIPK2 | 1.13324148 |
| 52 | MAPK11 | 1.13244616 |
| 53 | SIK1 | 1.11255229 |
| 54 | CAMK1D | 1.10587029 |
| 55 | JAK3 | 1.07665380 |
| 56 | LYN | 1.06381954 |
| 57 | TBK1 | 1.05640103 |
| 58 | CDC42BPA | 1.02436239 |
| 59 | SRPK1 | 1.02351660 |
| 60 | MARK2 | 1.02222397 |
| 61 | BRD4 | 1.01657388 |
| 62 | RPS6KA6 | 1.01649987 |
| 63 | BMPR2 | 1.00616757 |
| 64 | HCK | 0.98381659 |
| 65 | MAP3K1 | 0.97397708 |
| 66 | CDK7 | 0.96151476 |
| 67 | RPS6KC1 | 0.95645041 |
| 68 | RPS6KL1 | 0.95645041 |
| 69 | LCK | 0.93530622 |
| 70 | CAMK1G | 0.91736944 |
| 71 | PIM1 | 0.91060878 |
| 72 | CHUK | 0.89334304 |
| 73 | JAK2 | 0.88930221 |
| 74 | MAPK12 | 0.88261066 |
| 75 | ATR | 0.88214182 |
| 76 | TNIK | 0.88202436 |
| 77 | ITK | 0.86189128 |
| 78 | TESK2 | 0.86016298 |
| 79 | TNK2 | 0.85905550 |
| 80 | EPHB1 | 0.85296572 |
| 81 | PRKD2 | 0.85039151 |
| 82 | MAP3K2 | 0.84065642 |
| 83 | SIK2 | 0.83623823 |
| 84 | BMX | 0.81622598 |
| 85 | PLK4 | 0.81158366 |
| 86 | KSR2 | 0.80494112 |
| 87 | RIPK1 | 0.80353912 |
| 88 | SMG1 | 0.79782198 |
| 89 | SGK3 | 0.78744932 |
| 90 | MYLK | 0.77354228 |
| 91 | NLK | 0.76446806 |
| 92 | PTK2B | 0.74632817 |
| 93 | FES | 0.73939267 |
| 94 | FGFR4 | 0.73047564 |
| 95 | RET | 0.72037126 |
| 96 | TRPM7 | 0.70595721 |
| 97 | JAK1 | 0.69401999 |
| 98 | AKT3 | 0.67667524 |
| 99 | EPHA3 | 0.66400230 |
| 100 | TAOK3 | 0.65654901 |
| 101 | MAP2K6 | 0.64913449 |
| 102 | PDPK1 | 0.64716519 |
| 103 | MAPK13 | 0.64695002 |
| 104 | DYRK3 | 0.64622437 |
| 105 | PDK1 | 0.59420490 |
| 106 | PTK6 | 0.58394894 |
| 107 | TTN | 0.57231056 |
| 108 | CDC7 | 0.57003391 |
| 109 | CAMK4 | 0.56218413 |
| 110 | BRSK2 | 0.56060559 |
| 111 | PKN2 | 0.56004706 |
| 112 | MATK | 0.55332594 |
| 113 | CDK3 | 0.55181229 |
| 114 | CDK4 | 0.53133375 |
| 115 | PRPF4B | 0.52368343 |
| 116 | LRRK2 | 0.52256109 |
| 117 | MARK3 | 0.51803270 |
| 118 | STK10 | 0.51522056 |
| 119 | PAK4 | 0.50342572 |
| 120 | RPS6KA5 | 0.50337004 |
| 121 | PRKAA2 | 0.49972597 |
| 122 | RPS6KA2 | 0.49813981 |
| 123 | CLK1 | 0.47289641 |
| 124 | MAPKAPK3 | 0.45736684 |
| 125 | MAPK15 | 0.45606199 |
| 126 | PRKD1 | 0.45472863 |
| 127 | CDK9 | 0.43184653 |
| 128 | RPS6KB2 | 0.42654853 |
| 129 | MTOR | 0.42481982 |
| 130 | KDR | 0.41611362 |
| 131 | PDGFRB | 0.41440885 |
| 132 | CDK6 | 0.41276097 |
| 133 | MAPKAPK2 | 0.41088239 |
| 134 | MAPK3 | 0.40971881 |
| 135 | STK4 | 0.39226514 |
| 136 | CDK12 | 0.38950447 |
| 137 | WEE1 | 0.38752235 |
| 138 | MAPK4 | 0.38671268 |
| 139 | TAOK1 | 0.37721224 |
| 140 | CSK | 0.37307281 |
| 141 | PIK3CA | 0.37243939 |
| 142 | NEK2 | 0.36711527 |
| 143 | GSK3A | 0.36176700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.66681160 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.51125419 |
| 3 | Homologous recombination_Homo sapiens_hsa03440 | 2.34754366 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 2.34091692 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.33220933 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.31257948 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.18634420 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.14019223 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.12275038 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.10560703 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.08489604 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06013937 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.00254642 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98198359 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92783945 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90465958 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78048328 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.75891943 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73594641 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71684222 |
| 21 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.71598574 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68570882 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66841836 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49502211 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.48305621 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.48017594 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.43100267 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.42522801 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.40746768 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36288796 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35881535 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35692602 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30247626 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.29860787 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25195545 |
| 36 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.24441647 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23373848 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19992027 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.15562841 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 1.13498585 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13336160 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.11918711 |
| 43 | Cell cycle_Homo sapiens_hsa04110 | 1.11868681 |
| 44 | Ribosome_Homo sapiens_hsa03010 | 1.11725597 |
| 45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.08643737 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.08141096 |
| 47 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.07921634 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06686519 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.02547593 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02056220 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01145554 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 1.01118781 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.00744588 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99753911 |
| 55 | RNA degradation_Homo sapiens_hsa03018 | 0.97609324 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95637588 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91981717 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.90771156 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89601894 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89390641 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88958646 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.88082914 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.86158838 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83626232 |
| 65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83556831 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82574152 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81875383 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.79088670 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79075955 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.77728247 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76727672 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76248908 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75623384 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.75354642 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75288251 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75109220 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73752241 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72641780 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72581003 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.72492383 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72401060 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68414623 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66767621 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63603239 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61372732 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60197571 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.59555802 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59045943 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58714262 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.58336062 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.58130433 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56241474 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56182166 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55287302 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54888851 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54488803 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.54150328 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54130155 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52759550 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51818878 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51548114 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51296869 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.51005546 |
| 104 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50718929 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50351961 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50103328 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49764479 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48793824 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48503069 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47974738 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47641766 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47584707 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.46643681 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46285171 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.46005023 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.45858030 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43658770 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.41828532 |
| 119 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41464677 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41038980 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41002644 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.40972738 |
| 123 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40713776 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40702955 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40614053 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39902336 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39719867 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39694478 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39104011 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38721269 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37066530 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35769965 |
| 133 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35514282 |

